Williams James E, Moramarco Jacques
Emperor's College of Traditional Medicine, Santa Monica, CA, USA.
Med Acupunct. 2022 Jun 1;34(3):159-166. doi: 10.1089/acu.2021.0090. Epub 2022 Jun 16.
OBJECTIVE: To establish an evidence-based role for acupuncture as a safe and effective treatment for managing Long COVID in the integrative medical setting. BACKGROUND: COVID-19 progresses to a chronic state, termed Long COVID, in about 30% of cases with estimates as high as 40% for prolonged illness. Symptoms are diverse and range over several body systems, including unrelenting fatigue, persistent malaise, chronic pain, and mood changes. Early clinical reports suggest acupuncture can effectively address both symptoms and the underlying causes of Long COVID. EVIDENCE: Historically, acupuncture is well defined in Traditional Chinese Medicine writings to treat influenza-like febrile illnesses. Contemporary scientific literature and case studies support the value of acupuncture for symptoms associated with acute and chronic respiratory viral infections, such as influenza, including SARS and COVID-19. Recent reports provide early evidence of acupuncture's effectiveness in managing Long COVID symptoms and may also have disease-modifying benefits. CONCLUSION: Acupuncture is a viable adjunctive health care modality as part of a multidisciplinary approach for symptom control and disease management to improve quality of life in Long COVID patients. Since acupuncture may favorably modify the length and outcome of this condition, the model of acupuncture presented in this article warrants broader use in the integrative clinical setting and for further research.
目的:确立针灸在综合医疗环境中作为治疗新冠后长期症状安全有效疗法的循证作用。 背景:约30%的新冠病例会发展为慢性状态,即新冠后长期症状,长期患病者的这一比例估计高达40%。症状多样,涉及多个身体系统,包括持续疲劳、持续不适、慢性疼痛和情绪变化。早期临床报告表明,针灸能有效解决新冠后长期症状及其潜在病因。 证据:从历史上看,针灸在中医典籍中对治疗流感样发热性疾病有明确记载。当代科学文献和案例研究支持针灸对与急性和慢性呼吸道病毒感染相关症状的价值,如流感,包括非典和新冠。近期报告提供了针灸治疗新冠后长期症状有效性的早期证据,且可能还有改善病情的益处。 结论:针灸是一种可行的辅助医疗方式,作为多学科方法的一部分用于症状控制和疾病管理,以改善新冠后长期症状患者的生活质量。由于针灸可能对这种病症的病程和转归产生有利影响,本文介绍的针灸模式值得在综合临床环境中更广泛应用并作进一步研究。
Med Acupunct. 2022-6-1
Cell Mol Biol (Noisy-le-grand). 2024-9-8
Med Acupunct. 2017-10-1
Altern Ther Health Med. 2023-10
J Pediatr Hematol Oncol. 2008-6
Med Acupunct. 2022-6-1
Clin J Pain. 2010-1
J Altern Complement Med. 2020-9
Cochrane Database Syst Rev. 2018-12-18
Medicine (Baltimore). 2025-7-18
Medicine (Baltimore). 2025-5-2
Integr Med (Encinitas). 2025-4
J Pharmacopuncture. 2023-9-30
World J Acupunct Moxibustion. 2023-6-1
Medicine (Baltimore). 2022-3-11
Egypt Liver J. 2021
Proc Natl Acad Sci U S A. 2021-8-24
EClinicalMedicine. 2021-8
Evid Based Complement Alternat Med. 2021-7-8